147 related articles for article (PubMed ID: 38363074)
1. Antitrypanosomal Chloronitrobenzamides.
Carrillo AK; Kadayat TM; Hwang JY; Chen Y; Zhu F; Holbrook G; Gillingwater K; Connelly MC; Yang L; Kaiser M; Guy RK
J Med Chem; 2024 Mar; 67(5):3437-3447. PubMed ID: 38363074
[TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Jones AJ; Kaiser M; Avery VM
Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
4. Discovery of an orally active nitrothiophene-based antitrypanosomal agent.
Ajayi O; Metibemu DS; Crown O; Adeyinka OS; Kaiser M; Shoji N; Silva M; Rodriguez A; Ogungbe IV
Eur J Med Chem; 2024 Jan; 263():115954. PubMed ID: 37984297
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
[TBL] [Abstract][Full Text] [Related]
6. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
7. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.
Kaiser M; Bray MA; Cal M; Bourdin Trunz B; Torreele E; Brun R
Antimicrob Agents Chemother; 2011 Dec; 55(12):5602-8. PubMed ID: 21911566
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy.
Zheng Y; van den Kerkhof M; van der Meer T; Gul S; Kuzikov M; Ellinger B; de Esch IJP; Siderius M; Matheeussen A; Maes L; Sterk GJ; Caljon G; Leurs R
J Med Chem; 2023 Aug; 66(15):10252-10264. PubMed ID: 37471520
[TBL] [Abstract][Full Text] [Related]
9. Folates in Trypanosoma brucei: Achievements and Opportunities.
Cullia G; Tamborini L; Conti P; De Micheli C; Pinto A
ChemMedChem; 2018 Oct; 13(20):2150-2158. PubMed ID: 30152195
[TBL] [Abstract][Full Text] [Related]
10. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
11. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
[TBL] [Abstract][Full Text] [Related]
13. Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48.
Martínez-García M; Bart JM; Campos-Salinas J; Valdivia E; Martínez-Bueno M; González-Rey E; Navarro M; Maqueda M; Cebrián R; Pérez-Victoria JM
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):203-212. PubMed ID: 29649664
[TBL] [Abstract][Full Text] [Related]
14. Optimization of chloronitrobenzamides (CNBs) as therapeutic leads for human African trypanosomiasis (HAT).
Hwang JY; Smithson D; Zhu F; Holbrook G; Connelly MC; Kaiser M; Brun R; Guy RK
J Med Chem; 2013 Apr; 56(7):2850-60. PubMed ID: 23484493
[TBL] [Abstract][Full Text] [Related]
15. The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines.
Robinson WJ; Taylor AE; Lauga-Cami S; Weaver GW; Arroo RRJ; Kaiser M; Gul S; Kuzikov M; Ellinger B; Singh K; Schirmeister T; Botana A; Eurtivong C; Bhambra AS
Eur J Med Chem; 2021 Jan; 209():112871. PubMed ID: 33070078
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activities of 2-aminopyrazines and 2-aminopyridines in experimental models of human African trypanosomiasis.
Vodnala SK; Lundbäck T; Sjöberg B; Svensson R; Rottenberg ME; Hammarström LG
Antimicrob Agents Chemother; 2013 Feb; 57(2):1012-8. PubMed ID: 23254423
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis.
Nare B; Wring S; Bacchi C; Beaudet B; Bowling T; Brun R; Chen D; Ding C; Freund Y; Gaukel E; Hussain A; Jarnagin K; Jenks M; Kaiser M; Mercer L; Mejia E; Noe A; Orr M; Parham R; Plattner J; Randolph R; Rattendi D; Rewerts C; Sligar J; Yarlett N; Don R; Jacobs R
Antimicrob Agents Chemother; 2010 Oct; 54(10):4379-88. PubMed ID: 20660666
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma rhodesiense: evaluation of the antitrypanosomal action of 2,5-bis(4-guanylphenyl)furan dihydrochloride.
Steck EA; Kinnamon KE; Davidson DE; Duxbury RE; Johnson AJ; Masters RE
Exp Parasitol; 1982 Feb; 53(1):133-44. PubMed ID: 7056341
[No Abstract] [Full Text] [Related]
19. Oral administration of azithromycin ameliorates trypanosomosis in Trypanosoma congolense-infected mice.
Molefe NI; Yamasaki S; Macalanda AMC; Suganuma K; Watanabe K; Xuan X; Inoue N
Parasitol Res; 2017 Sep; 116(9):2407-2415. PubMed ID: 28674747
[TBL] [Abstract][Full Text] [Related]
20. [Horizon 2000: what are the perspectives for African trypanosomiasis?].
De Raadt PP
Bull Soc Pathol Exot; 1994; 87(5):301-2. PubMed ID: 7496188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
